A Study to Evaluate the Safety and Tolerability of PCS499 for the Treatment of Necrobiosis Lipoidica
Clinical trial NCT03698864 · COMPLETED
Trial details
- NCT number
- NCT03698864
- Sponsor
- Processa Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-07
- Primary completion
- 2020-02-25
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.